The Latest Updates in Pediatric Cancer Predisposition with Jaclyn Schienda, ScM, CGC

• The field of pediatric cancer predisposition has been rapidly growing.  This presentation will discuss the evolution of genetic testing and identification of children with cancer predisposition syndromes. Ms. Schienda will highlight the expanding phenotypes of known syndromes and will discuss the tenets of current and future surveillance programs.  DICER1- syndrome will be used as a model throughout the presentation.

  Level of Instruction: Intermediate

  

  Only the live session qualifies for CEUs but when possible, we host the recordings on our website and NSGC recommends participants to use their personal email instead of work email addresses to ensure they receive their CEU certificates.

  

  Ambry Genetics is approved as a provider for continuing education program by NSGC and ASCLS P.A.C.E ® Program.

Jaclyn Schienda, ScM, CGC | Presenter

Lead Genetic Counselor, Pediatric Cancer Genetic Risk Program & Bone Marrow Failure and MDS Program, Dana-Farber Cancer Institute/ Boston Children's Hospital

Jaclyn Schienda is the Lead Genetic Counselor of the Pediatric Cancer Genetic Risk Program (PCGRP) and the Bone Marrow Failure/MDS Program at the Dana-Farber Cancer Institute and Boston Children's Hospital. She graduated from the Johns Hopkins University joint genetic counseling training program with the National Human Genome Research Institute at the NIH in 2008. She joined Dana-Farber in 2012 after working in a busy general genetics clinic. 

At Dana-Farber, she co-led the establishment of the PCGRP and continues to build the program. She has a special interest in communication of genetic risk and health information to children and families.   She is also actively involved in many research projects which study the expanding phenotypes of and surveillance for pediatric cancer predisposition syndromes, as well as the psychological impact on children and families.

Kelly Burgess, MS, CGC | Moderator

Genomic Science Liaison, Ambry Genetics

Kelly Burgess is a certified genetic counselor and a Genomic Science Liaison with Ambry Genetics.  She earned an MS in genetic counseling from Wayne State University in 2014. She has been working with Ambry since February 2020 and provides clinical and technical support for hereditary cancer testing to providers across multiple states, including Illinois, Wisconsin, Minnesota, and the Dakotas. Prior to joining Ambry, she worked as a clinical cancer genetic counselor for 6 years with the bulk of her clinical time spent at Rush University Medical Center in Chicago, IL.